sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology Europe RNAi Therapeutics Market...

Europe RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)), Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases, and Others), Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others), and End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals) Geography

TIPRE00015148 | Pages: 136 | Biotechnology | Oct 2020 | Type: Regional | Status: Published

Market Introduction

RNA interference (RNAi) is a vital biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. RNAi is an essential research tool in cell culture and living organisms because synthetic dsRNA introduced into cells can induce the suppression of specific genes of interest. RNAi may be used for large-scale screens that orderly shutdown each gene in the cell, which can help to know the components necessary for a particular cellular event such as cell division. The pathway is also used as a practical tool in medicine, biotechnology, and insecticides.


Get more information on this report :



Market Overview and Dynamics

The Europe RNAi therapeutics market is expected to reach US$ 324.33 million in 2027 from US$ 170.42 million in 2019. The market is anticipated to grow at a CAGR of 8.4% during 2019–2027. The growth of the market is attributed to some key driving factors such as growing investments in RNAi therapies and rising prevalence of infectious diseases & chronic conditions. However, high cost of RNAi therapy development is expected to obstruct the growth of the market to a certain extent during the forecast years.

Key Market Segments

In terms of molecule type, the small interfering RNAs (siRNA) segment accounted for the largest share of the Europe RNAi therapeutics market in 2019. In terms of route of administration, the pulmonary delivery segment accounted for the largest share of the Europe RNAi therapeutics market in 2019. In terms of application, oncology segment accounted for the largest share of the Europe RNAi therapeutics market in 2019. In terms of end user, research and academic laboratories segment accounted for the largest share of the Europe RNAi therapeutics market in 2019

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Europe RNAi therapeutics market report are the World Health Organization (WHO), British Lung Foundation, Cancer Research UK, International Trade Administration (ITA), European Federation of Pharmaceutical Industries and Associations (EFPIA) and others.

Reasons to buy report

  • It provides understanding of the Europe, RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe RNAi therapeutics market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of RNAi therapeutics market performance of various segments pertaining to the Europe RNAi therapeutics market.
  • It provides RNAi therapeutics market revenue forecast of the market based on various segments for the period from 2019 to 2027.

EUROPE RNAI THERAPEUTICS MARKET SEGMENTATION

By Molecule Type

  • Small Interfering RNAs (siRNA)
  • MicroRNA (miRNA)

By Route of Administration

  • Pulmonary Delivery
  • Intravenous Injections
  • Intradermal Injections
  • Intraperitoneal Injections
  • Others

By Application

  • Oncology
  • Cardiovascular
  • Respiratory Disorders
  • Renal Diseases
  • Genetic Disorders
  • Neurodegenerative Disorders
  • Infectious Diseases
  • Others

By End User

  • Research and Academic Laboratories
  • Hospitals
  • Diagnostic Laboratories

 

By Country

  • Germany
  • UK
  • France
  • Italy
  • Spain

 

Company Profiles

  • Sanofi
  • GlaxoSmithKline plc
  • Silence Therapeutics
  • Alnylam Pharmaceuticals, Inc
  • Arrowhead Pharmaceuticals, Inc

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe RNAi Therapeutics Market – By Molecule Type

1.3.2        Europe RNAi Therapeutics Market – By Application

1.3.3        Europe RNAi Therapeutics Market – By Route of Administration

1.3.4        Europe RNAi Therapeutics Market– By End User

1.3.5        Europe RNAi Therapeutics Market – By Country

2.          Europe RNAi Therapeutics Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe RNAi Therapeutics Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        RNAi therapeutics Market - Europe PEST Analysis

4.3        Expert Opinion

5.          Europe RNAi Therapeutics Market - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Growing Investments in RNAi Therapies

5.1.2        Rising Prevalence of Chronic Conditions and Infectious Diseases

5.2        Market Restraints

5.2.1        High Cost for RNAi Therapy Development

5.3        Market Opportunities

5.3.1        Significant Number of Pipeline Candidates for Strategic Alliances

5.4        Future Trends

5.4.1        Rising Emphasis on RNA Technologies

5.5        Impact analysis

6.          RNAi Therapeutics Market – Europe Analysis

6.1        Europe RNAi Therapeutics Market Revenue Forecasts and Analysis

7.          Europe RNAi Therapeutics Market Analysis and Forecasts To 2027 – By Molecule Type

7.1        Overview

7.2        Europe RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

7.2.1        Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)

7.3        Small Interfering RNAs (siRNA)

7.3.1        Overview

7.3.2        Europe Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)

7.4        MicroRNA (miRNA)

7.4.1        Overview

7.4.2        Europe MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8.          Europe RNAi therapeutics Market Analysis and Forecasts To 2027 – By Application

8.1        Overview

8.2        Europe RNAi therapeutics Market, By Application 2019 & 2027 (%)

8.2.1        Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3        Genetic Disorders

8.3.1        Overview

8.3.2        Europe Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)

8.4        Oncology

8.4.1        Overview

8.4.2        Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5        Neurodegenerative Disorders

8.5.1        Overview

8.5.2        Europe Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.6        Cardiovascular Disorders

8.6.1        Overview

8.6.2        Europe Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.7        Respiratory Disorders

8.7.1        Overview

8.7.2        Europe Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.8        Infectious Diseases

8.8.1        Overview

8.8.2        Europe Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.9        Renal Diseases

8.9.1        Overview

8.9.2        Europe Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Other Disorders

8.10.1     Overview

8.10.2     Europe Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Europe RNAi therapeutics Market Analysis and Forecasts To 2027 – By Route of Administration

9.1        Overview

9.2        Europe RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

9.2.1        Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

9.3        Intradermal Injections

9.3.1        Overview

9.3.2        Europe Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)

9.4        Pulmonary Delivery

9.4.1        Overview

9.4.2        Europe Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Intravenous Injections

9.5.1        Overview

9.5.2        Europe Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Intraperitoneal Injections

9.6.1        Overview

9.6.2        Europe Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Other Route of Administrations

9.7.1        Overview

9.7.2        Europe Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Europe RNAi Therapeutics Market Analysis – By End-User

10.1      Overview

10.2      Europe RNAi Therapeutics Market, By End-User 2019-2027 (%)

10.2.1     Europe RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

10.3      Diagnostic Laboratories

10.3.1     Overview

10.3.2     Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.4      Research and Academic Laboratories

10.4.1     Overview

10.4.2     Europe Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.5      Hospitals

10.5.1     Overview

10.5.2     Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11.       RNAi therapeutics Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Europe: RNAi Therapeutics Market

11.1.1     Overview

11.1.2     Europe: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     Europe RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.4     Europe RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.5     Europe RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.6     Europe RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7     Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)

11.1.8     Germany: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       Germany: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       Germany RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.8.3       Germany RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.8.4       Germany RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.8.5       Germany RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.9     UK: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       UK: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       UK RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.9.3       UK RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.9.4       UK RNAi Therapeutics Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

11.1.9.5       UK: RNAi Therapeutics Market, End User – Revenue and Forecast to 2027 (USD Million)

11.1.10   France: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    France: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    France RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.10.3    France RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.10.4    France RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.10.5    France RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.11   Spain: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    Spain: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    Spain RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.11.3    Spain RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.11.4    Spain RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.11.5    Spain RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.12   Italy: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Italy: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Italy RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

11.1.12.3    Italy RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.12.4    Italy RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.12.5    Italy RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

12.       Impact of COVID-19 Pandemic on Europe RNAi therapeutics Market

12.1      Europe: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1      Sanofi

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Silence Therapeutics

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Alnylam Pharmaceuticals, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Arrowhead Pharmaceuticals, Inc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.            Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)

Table 2.            Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.            Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 4.            Europe RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 5.            Europe RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            Europe RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.            Europe RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.            Europe RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.            Germany RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          Germany RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Germany RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 12.          Germany RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          United Kingdom RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          United Kingdom RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          UK: RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million).

Table 16.          UK: RNAi Therapeutics Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          France RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          France RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.          France RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 20.          France RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Spain RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Spain RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 23.          Spain RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 24.          Spain RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Italy RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Italy RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 27.          Italy RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 28.          Italy RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 29.          Glossary of Terms, RNAi Therapeutics Market

LIST OF FIGURES

Figure 1.           RNAi Therapeutics Market Segmentation

Figure 2.           Europe RNAi Therapeutics Market Overview

Figure 3.           Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe RNAi Therapeutics Market - Leading Country Markets (US$ Mn)

Figure 6.           RNAi Therapeutics Market - Europe PEST Analysis

Figure 7.           RNAi Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.           Europe RNAi Therapeutics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Europe RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

Figure 10.        Europe Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Europe MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe RNAi therapeutics Market, By Application 2019 & 2027 (%)

Figure 13.        Europe Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Europe Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Europe Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Europe Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Europe Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Europe Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

Figure 22.        Europe Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Europe Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Europe Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Europe Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Europe Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Europe RNAi Therapeutics Market, by End-User 2019 & 2027 (%)

Figure 28.        Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Europe Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.        Europe: RNAi Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 32.        Europe RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 33.        Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)

Figure 34.        Germany: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        UK: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        France: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Spain: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Italy: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic in Europe Country Markets

  1. Sanofi
  2. GlaxoSmithKline plc
  3. Silence Therapeutics
  4. Alnylam Pharmaceuticals, Inc
  5. Arrowhead Pharmaceuticals, Inc
  • It provides understanding of the Europe, RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe RNAi therapeutics market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of RNAi therapeutics market performance of various segments pertaining to the Europe RNAi therapeutics market.
  • It provides RNAi therapeutics market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription